11/18
08:07 am
cldi
Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer [Yahoo! Finance]
Low
Report
Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer [Yahoo! Finance]
11/18
08:00 am
cldi
Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer
Medium
Report
Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer
11/15
04:05 pm
cldi
Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock
Medium
Report
Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock
11/14
08:30 am
cldi
Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock
High
Report
Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock
11/13
04:33 pm
cldi
Calidi Biotherapeutics Announces Proposed Public Offering
High
Report
Calidi Biotherapeutics Announces Proposed Public Offering
11/12
05:33 pm
cldi
Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results [Yahoo! Finance]
High
Report
Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results [Yahoo! Finance]
11/12
05:29 pm
cldi
Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results
High
Report
Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results
10/24
08:30 am
cldi
Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences
Low
Report
Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences
10/23
08:31 am
cldi
Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement
High
Report
Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement
10/18
11:00 pm
cldi
NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)
High
Report
NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)
9/30
08:00 am
cldi
Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma
Medium
Report
Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma